Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-24-103408
Filing Date
2024-11-27
Accepted
2024-11-27 15:19:32
Documents
83
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO FORM 10-Q ea022216501-10qa3_bioess.htm   iXBRL 10-Q/A 584410
2 CERTIFICATION ea022216501ex31-1_bioess.htm EX-31.1 17491
3 CERTIFICATION ea022216501ex32-1_bioess.htm EX-32.1 10482
4 GRAPHIC image_001.jpg GRAPHIC 7166
  Complete submission text file 0001213900-24-103408.txt   4993124

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE bioe-20240331.xsd EX-101.SCH 53876
6 XBRL CALCULATION FILE bioe-20240331_cal.xml EX-101.CAL 59314
7 XBRL DEFINITION FILE bioe-20240331_def.xml EX-101.DEF 257480
8 XBRL LABEL FILE bioe-20240331_lab.xml EX-101.LAB 413123
9 XBRL PRESENTATION FILE bioe-20240331_pre.xml EX-101.PRE 265266
86 EXTRACTED XBRL INSTANCE DOCUMENT ea022216501-10qa3_bioess_htm.xml XML 486258
Mailing Address 2955 MAIN STREET STE 300 IRVINE CA 92614
Business Address 2955 MAIN STREET STE 300 IRVINE CA 92614 888-816-1494
Bio Essence Corp (Filer) CIK: 0001723059 (see all company filings)

EIN.: 943349551 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-56263 | Film No.: 241510534
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)